Researchers from the MIPT Institute of Future Biophysics developed a novel two-stage method for targeted delivery of cancer medications, whose main feature is its entirely biological foundation. The system self-assembles from proteins produced by specially modified bacteria.
The project lead, Doctor of Biological Sciences Victoria Shapunova, explained in an interview with “Radio 1” that the essence of the work is to obtain the necessary nanoparticles not through chemical means in a laboratory, but using living bacteria.
This allows for the realization of the “magic bullet” concept, formulated over a century ago: “an ideal agent that locates the illness without harming the patient,” she clarified.
Victoria Shapunova shared that preclinical trials are currently completed, and the patent registration process is underway. The next phase is preparation for human trials, for which contacts have already been established with an oncology center. Furthermore, the scientists intend to adapt the technology for pancreatic cancer, and they are also negotiating joint work with other Russian biotech firms.
About the Author
